fda on compounded tirzepatide confirms shortage is still over, gives compounders a grace period The FDA is proposing a

Dec 14: Merck scored a second approval for HIF-2 inhibitor Welireg (belzutifan), this one in advanced renal cell carcinoma (RCC)

Gastrointestinal side effects are among the most commonly reported adverse reactions with GLP-1 receptor agonists, and acid reflux (gastro-oesophageal reflux) and heartburn feature prominently in patient experiences

Or you're having to rely on harsh anxiety-laced stimulants that can severely impact your heart & take years off your life

These may include surgical removal of tumours, medications that block cortisol production (such as metyrapone or ketoconazole), or in some cases, adrenalectomy

There is no pharmacologically "best" day

The chart below will help you break it down